RS
LEGN icon

Rakuten Securities’s Legend Biotech LEGN Stock Holding History

Rakuten Securities’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Buy
8,005
+8,000
+160,000% +$216K 0.05% 138
2026
Q1 		$90 Hold
5
– – ﹤0.01% 837
2025
Q4 		$109 Hold
5
– – ﹤0.01% 845
2025
Q3 		$163 Hold
5
– – ﹤0.01% 840
2025
Q2 		$177 Hold
5
– – ﹤0.01% 774
2025
Q1 		$170 Sell
5
-61
-92% -$2.19K ﹤0.01% 769
2024
Q4 		$2.15K Sell
66
-10
-13% -$414 ﹤0.01% 557
2024
Q3 		$3.7K Buy
+76
New +$4.05K ﹤0.01% 448

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Rakuten Securities's LEGN Position: Q2 2026 in Review

Rakuten Securities increased its Legend Biotech (LEGN) stake by 160,000% in Q2 2026, buying an estimated $216K and bringing the position to 8,005 shares worth $231K. The position accounts for 0.05% of the portfolio, ranked #138.

Rakuten Securities first reported a position in LEGN in Q3 2024 and has held it in 8 quarters since. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Rakuten Securities held 8,005 shares of Legend Biotech worth $231K as of Q2 2026.
  • Rakuten Securities bought 8,000 Legend Biotech shares in Q2 2026, an estimated $216K.
  • Legend Biotech made up 0.05% of Rakuten Securities's portfolio in Q2 2026, its #138 holding.
  • Rakuten Securities first reported a position in Legend Biotech in Q3 2024 and has held it in 8 quarters since.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.